Compass Pathways (CMPS)

• Market cap: $1.53B
• 1 day: -1.99%
• 5 days: 0.71%
• 1 month: -19.86%
• 3 months: 25.17%
• 6 months: 71.56%
• Year to date: 73.13%
• 1 year: 160.69%
• 5 years: -66.59%
• 10 years: -60.9%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Employees: 156